Skip to main content

Epigenetics Market | Latest Trend Shows Growth Opportunities in Personalized Medicine and Targeted Therapy

The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years.

Growing applications in Personalized Medicine and Targeted Therapy in Oncology is a growth opportunity for the Epigenetics Market
According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years, and these investments are further expected to increase by 33% over the next five years. This will further drive the use of epigenetics tools. A 2016 study performed to analyze the epigenetic modification of chronic lymphocytic leukemia (CLL) in the patient population fueled interest in prognostic biomarkers and personalized therapies. This study was performed by CeMM Research Center for Molecular Medicine of the Austrian Academy of Science (Austria) in collaboration with the University of Southampton and the Royal Bournemouth Hospital under the European BLUEPRINT project and the International Human Epigenome Consortium. The expanding application of epigenetics in personalized medicine and targeted therapies, therefore, offers significant opportunities for market growth.

Download Free Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896

epigenetics-technologies-market11

Major Market Developments:

  • In July 2017, Agilent launched AriaDx Real-Time PCR System
  • In June 2017, Illumina launched Extended RAS Panel, a NGS kit
  • In January 2017, Illumina entered into an agreement with Koninklijke Philips (Netherlands) to integrate Ilumina’s sequencing systems with Philips’ IntelliSpace Genomics clinical informatics platform for oncology

The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2017, growing at a CAGR of 13.3%.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=896
Labels:

Comments

Post a Comment

Popular posts from this blog

Temperature Monitoring Systems Market | 3M (US) and Omega Engineering (US) are Leading Players

Analysis of the developments in the temperature monitoring systems market from 2016 to 2018 shows that new product launches, geographic expansions, mergers & acquisitions, and contracts were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions. Some of the prominent players in the temperature monitoring systems market are 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (Subsidiary Of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), and Omega Engineering (US). The growth of this market is driven by rising manufacturing activity across a range of industries, as well as stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors). Technological advancements have introduced systems that are more efficient and capable of meeting a greater variety of needs...
Post a Comment
Read more

Dental Bone Graft Substitutes Market | Key Market Players

The global dental bone graft substitutes market is expected to reach USD 664.3 million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as growing aging population, growing medical and dental tourism in developing countries, and increasing disposable income in developing countries across the globe are fueling the growth of this market. The major players operating in global dental bone graft substitutes market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea). The global dental bone graft substitutes market is fragmented and competitive, with a significant number of global and regional market players. This report studies the growth strategies adopted by key market players between 2013 and 2015. Leading players in the dental bone graft subst...
Post a Comment
Read more

Cranial Fixation & Stabilization Systems Market 2019 | Top 5 Major Factors Driving Market Growth

Market Growth Factors: The increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries are the key drivers for the global cranial fixation and stabilization systems market . What Expert Analysed About The Market Growth: The global cranial fixation and stabilization systems market is expected to reach USD 1.74 billion by 2022 from USD 1.14 billion in 2017, at a CAGR of 8.7% . Market Segmentation: The cranial fixation and stabilization systems market is segmented on the basis of product, material type, end user, and region. Download FREE Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197152289 “Cranial fixation systems are expected to grow at the highest CAGR during the forecast period.” Based on product, the market is segmented into cranial fixation systems and cranial stabilization systems. The cranial fixation systems segment is expected to grow at the highest CAGR during the forecast period. The large share of th...
Post a Comment
Read more